Showing 821-830 of 4590 results for "".
- Sciton Expanding in Canadahttps://practicaldermatology.com/news/20120229-sciton_expanding_in_canada/2459860/Sciton, Inc., is establishing a direct presence in Canada. Noting a very strong and loyal customer base within Canada, the company says it views the Canadian market as an integral part of its corporate growth strategy. Sciton will expand its marketing, sales, clinical education and service offerings
- ARTAS System Receives Canadian Medical Device License to Treat Hair Losshttps://practicaldermatology.com/news/20120229-artas_system_receives_canadian_medical_device_license_to_treat_hair_loss/2459861/Restoration Robotics, Inc., a privately-held medical device company, today announced that its revolutionary ARTAS™ System has received a Canadian Medical Device License and can now be marketed and sold within Canada. The physician controlled ARTAS™ System allows them to quickly identify and harvest
Canadian Perspective: Drs. Bhatia, Sapijaszko, and Kaufmann
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/canadian-perspective-drs-bhatia-sapijaszko-and-kaufmann/32695/Neal Bhatia, MD, speaks with Canadian Dermatology Association vice president Mariusz Sapijaszko, MD, FAACS, and former American Academy of Dermatology president Mark Kaufmann, MD, about different perspectives on advocacy in dermatology, including the use of patient stories.Terrence Keaney, MD, FAAD
https://practicaldermatology.com/topics/practice-management/terrence-keaney-md-faad/20644/Making the leap to private practice in 2017D as in Delta: The Changing Views on Vitamin D in Dermatology
https://practicaldermatology.com/topics/atopic-dermatitis/d-as-in-delta-the-changing-views-on-vitamin-d-in-dermatology/23616/Evidence suggests that vitamin D supplementation may benefit some patients with AD.Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabThe Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiLasers In Practice: Reducing the Appearance of Stretch Marks with Multiple Laser Technologies
https://practicaldermatology.com/topics/general-topics/lasers-in-practice-reducing-the-appearance-of-stretch-marks-with-multiple-laser-technologies/21769/Traditionally difficult to treat, stretch marks may respond to a combination of modalities provided in sync.Charles Crutchfield III, MD, FAAD
https://practicaldermatology.com/topics/practice-management/charles-crutchfield-iii-md-faad/21433/Vitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown.